Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey

Figure 1 Inflammatory bowel disease patients at low, moderate and high risk for complications of coronavirus disease 2019 and coronavirus disease-related deaths in Brazil by state (per 100000 people). A: Low risk; B: Moderate risk; C: High risk; D: Coronavirus disease 2019 deaths. COVID: Coronavirus disease; IBD: Inflammatory bowel disease.

Figure 2 Spearman correlation test between the 27 states and cumulative coronavirus disease 2019 mortality rates. No significant correlation was identified (r = 0.146, P = 0.467). COVID-19: Coronavirus disease 2019; IBD: Inflammatory bowel disease.